TrialBlood2010

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.

Jonathan E Kolitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.